Showing 961-970 of 4169 results for "".
MATV News: RealSelf Worth It Ratings; Cutera and Candela Launches; FDA Approves Qbrexza
https://beta.modernaesthetics.com/series/matv-news/matv-news-realself-worth-it-ratings-cutera-and-candela-launches-fda-approves-qbrexza/33264/Demand for fat reduction and interest in vaginal rejuvenation at all-time high, RealSelf reports, Cutera and Candela both launch new devices, and there's a new FDA-approved treatment for hyperhidrosis. Plus, find out how the first #RealDealAesthetics Twitter Chat went, and share your thoughts on choMATV News: Restylane Lyft for Hands; Positive Results for ThermiVa; Rosacea Burden
https://beta.modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-for-hands-positive-results-for-thermiva-rosacea-burden/33270/Restylane Lyft is now approved to fill the dorsal hands, #WeAllGrow Latina Network in favor of body contouring procedures, a new study on ThermiVa shows positive results, and Galderma shares results of global survey on rosacea showing need for physicians to open a dialogue with patients suffering frFix These Website Flaws Now
https://modernaesthetics.com/ma-issues-index/2018-may-june/fix-these-website-flaws-now/34113/Simple coding errors may be sabotaging your rankings.MATV News: RealSelf Fellowship Winners; Marie Osmond on MD Complete; New Devices for the Aesthetic Market
https://beta.modernaesthetics.com/series/matv-news/matv-news-realself-fellowship-winners-marie-osmond-on-md-complete-new-devices-for-the-aesthetic-market/33291/RealSelf has named the 2018 recipients of the RealSelf Fellowship, Marie Osmond talks about her new role as Strategic Advisor and Owner of MD Complete, and Cutera and Cynosure introduce new devices to the aesthetic market. Plus, should facial exercises be part of an anti-aging regimen?MATV News: Hair Restoration Procedures on the Rise; FDA Approvals; New Digital Marketing Book
https://beta.modernaesthetics.com/series/matv-news/matv-news-hair-restoration-procedures-on-the-rise-fda-approvals-new-digital-marketing-book/33312/The latest statistics from the ISHRS show hair restoration procedures are on the rise, Galderma's Restylane Silk is now approved for injection via cannula, and the FDA cleared Solta's new Thermage FLX. Plus, a look at a new book by marketing expert Wendy Lewis on best practices for social media andMATV News: The Art of Injecting; Chemicals in Beauty Products; Neurotoxin Pipeline
https://beta.modernaesthetics.com/series/matv-news/matv-news-the-art-of-injecting-chemicals-in-beauty-products-neruotoxin-pipeline/33322/A highly detailed body painting project is helping physicians better improve botulinum toxin injection techniques, a new study shows women with skin of color have higher levels of beauty-product related chemicals in their bodies, and a neuromodulator in the pipeline is showing promise. And, a look aMATV News: New CEOs at Top-Tier Aesthetic Companies; Allergan Vollure Launch and Other News
https://beta.modernaesthetics.com/series/matv-news/matv-news-new-ceos-at-top-tier-aesthetic-companies-allergan-vollure-launch-and-other-news/33342/Both Merz North America and Revision Skincare introduce new CEOs and Apax Partners buy all outstanding shares of Syneron stock. Also in this episode, Allergan launches Juvéderm Vollure and announces new Senior Vice President of Global Investor Relations and Strategy. Plus, is there a golden ratio whMATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://beta.modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aPredictions and Predilections
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/predictions-and-predilections/34315/Aesthetic experts foretell what's in store for 2017.MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://beta.modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus Velocity